Effect of Size and Concentration of PLGA-PEG Nanoparticles on Activation and Aggregation of Washed Human Platelets
Open Access
- 4 October 2019
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 11 (10) , 514
Abstract
Nanotechnology is being increasingly utilised in medicine as diagnostics and for drug delivery and targeting. The small size and high surface area of nanoparticles (NPs), desirable properties that allow them to cross biological barriers, also offer potential for interaction with other cells and blood constituents, presenting possible safety risks. While NPs investigated are predominantly based on the biodegradable, biocompatible, and FDA approved poly-lactide-co-glycolide (PLGA) polymers, pro-aggregatory and antiplatelet effects have been reported for certain NPs. The potential for toxicity of PLGA based NPs remains to be examined. The aims of this study were to determine the impact of size-selected PLGA-PEG (PLGA-polyethylene glycol) NPs on platelet activation and aggregation. PLGA-PEG NPs of three average sizes of 112, 348, and 576 nm were formulated and their effect at concentrations of 0.0–2.2 mg/mL on the activation and aggregation of washed human platelets (WP) was examined. The results of this study show, for the first time, NPs of all sizes associated with the surface of platelets, with >50% binding, leading to possible internalisation. The NP-platelet interaction, however, did not lead to platelet aggregation nor inhibited aggregation of platelets induced by thrombin. The outcome of this study is promising, suggesting that these NPs could be potential carriers for targeted drug delivery to platelets.Keywords
Funding Information
- King Abdulaziz University in Jeddah, Saudi Arabia and the Ministry of Higher Education in Saudi Arabia. (N/A)
This publication has 35 references indexed in Scilit:
- Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamideJournal of Pharmacy and Pharmacology, 2013
- Deciphering the mechanisms of cellular uptake of engineered nanoparticles by accurate evaluation of internalization using imaging flow cytometryParticle and Fibre Toxicology, 2013
- Amorphous silica nanoparticles aggregate human platelets: potential implications for vascular homeostasisInternational Journal of Nanomedicine, 2012
- Biodegradable Nanoparticles of mPEG-PLGA-PLL Triblock Copolymers as Novel Non-Viral Vectors for Improving siRNA Delivery and Gene SilencingInternational Journal of Molecular Sciences, 2012
- The use of quartz crystal microbalance with dissipation (QCM-D) for studying nanoparticle-induced platelet aggregationInternational Journal of Nanomedicine, 2012
- Enabling Anticancer Therapeutics by Nanoparticle Carriers: The Delivery of PaclitaxelInternational Journal of Molecular Sciences, 2011
- Multi-stage delivery nano-particle systems for therapeutic applicationsBiochimica et Biophysica Acta (BBA) - General Subjects, 2011
- Pegylation of poly(γ-benzyl-L-glutamate) nanoparticles is efficient for avoiding mononuclear phagocyte system capture in ratsInternational Journal of Nanomedicine, 2010
- Biologic Nanoparticles and Platelet ReactivityNanomedicine, 2009
- Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profilesNanomedicine: Nanotechnology, Biology and Medicine, 2009